Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: Evidence-based policy position statement of american society of interventional pain physicians (ASIPP)
Laxmaiah Manchikanti, Christopher J. Centeno, Sairam Atluri, Sheri L. Albers, Shane Shapiro, Gerard A. Malanga, Alaa Abd-Elsayed, Mairin Jerome, Joshua A. Hirsch, Alan D. Kaye, Steve M. Aydin, Douglas Beall, Don Buford, Joanne Borg-Stein, Ricardo Buenaventura, Joseph A. Cabaret, Aaron K. Calodney, Kenneth D. Candido, Cameron Cartier, Richard LatchawSudhir Diwan, Ehren Dodson, Zachary Fausel, Michael Fredericson, Christopher G. Gharibo, Mayank Gupta, Adam M. Kaye, Nebojsa Nick Knezevic, Radomir Kosanovic, Matthew Lucas, Maanasa V. Manchikanti, R. Amadeus Mason, Kenneth Mautner, Samuel Murala, Annu Navani, Vidyasagar Pampati, Sarah Pastoriza, Ramarao Pasupuleti, Cyril Philip, Mahendra Sanapati, Theodore Sand, Rinoo Shah, Amol Soin, Ian Stemper, Bradley W. Wargo, Philippe Hernigou
Dive into the research topics of 'Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: Evidence-based policy position statement of american society of interventional pain physicians (ASIPP)'. Together they form a unique fingerprint.